Positive Phase 2B Results for Treatment-Resistant Depression
Atai Life Sciences and Beckley Psytech announced positive topline results from a Phase 2b trial of BPL-003 (intranasal mebufotenin)...
UK MHRA Approves First-in-Human Trial of RinCell-1 for Hearing Loss
Rinri Therapeutics received approval from the UK MHRA to begin its first-in-human clinical trial for Rincell-1, a regenerative cell...
ReproNovo’s RPN-001 Enters US Phase 2 Trial for Male Infertility
ReproNovo has initiated a Phase 2 clinical trial for RPN-001 (leflutrozole), an oral aromatase inhibitor designed to treat male...
Invivyd & SPEAR Study Group Launch Long COVID Monoclonal Antibody Therapy Research
Invivyd formed the SPEAR Study Group to investigate the potential of monoclonal antibody therapy for Long COVID and Post-Vaccination...
Instil Bio’s AXN-2510 Gets FDA IND Clearance for Phase 1 Solid Tumor Trial
Instil Bio announced FDA clearance of its Investigational New Drug (IND) application for AXN-2510 (’2510), a PD-L1xVEGF bispecific antibody....
Novo Nordisk Targets 10% Efficiency Boost with Veeva Partnership
At the 2025 Veeva R&D and Quality Summit, Stephanie Bova, Digital Transformation Officer of Drug Development at Novo Nordisk,...
New Clinical Trial Data: Vivo Technology Shows Promise in Treating Pediatric Sleep Apnea
A recent multi-center clinical trial published in the European Journal of Pediatrics demonstrated the safety and efficacy of Vivos...
Entera Bio’s EB613 Shows Promising Effects on Bone Health in Post-Menopausal Women
Entera Bio announced that data from its Phase 2 study of EB613, an oral PTH(1-34) treatment for osteoporosis, was...
Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311
Invivyd announced positive Phase 1/2 clinical trial data for VYD2311, its next-generation monoclonal antibody designed to prevent and treat...
Altimmune Announces Positive Topline Results for Pemvidutide
Altimmune, Inc. announced positive topline results from its Phase 2b IMPACT trial of pemvidutide for metabolic dysfunction-associated steatohepatitis (MASH)....